Arising either from beta cell dysfunction and insulin resistance, or from autoimmune cell-mediated pancreatic islet cell destruction and resultant lack of insulin, treatments are usually aimed at glycaemic control, or reducing insulin resistance. Here, INS is linked to Insulin resistance.